To include your compound in the COVID-19 Resource Center, submit it here.

Pioglitazone: Interim data

In a placebo-controlled, double-blind study in 55 evaluable NASH patients, pioglitazone led to metabolic

Read the full 140 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE